BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

502 related articles for article (PubMed ID: 17306645)

  • 1. Vasomotor symptoms in menopause: physiologic condition and central nervous system approaches to treatment.
    Rapkin AJ
    Am J Obstet Gynecol; 2007 Feb; 196(2):97-106. PubMed ID: 17306645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vasomotor symptoms in menopause: where we've been and where we're going.
    Pinkerton JV; Zion AS
    J Womens Health (Larchmt); 2006 Mar; 15(2):135-45. PubMed ID: 16536677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of menopause-associated vasomotor symptoms: position statement of The North American Menopause Society.
    North American Menopause Society
    Menopause; 2004; 11(1):11-33. PubMed ID: 14716179
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Psychosocial and socioeconomic burden of vasomotor symptoms in menopause: a comprehensive review.
    Utian WH
    Health Qual Life Outcomes; 2005 Aug; 3():47. PubMed ID: 16083502
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Menopausal hot flushes and night sweats: where are we now?
    Archer DF; Sturdee DW; Baber R; de Villiers TJ; Pines A; Freedman RR; Gompel A; Hickey M; Hunter MS; Lobo RA; Lumsden MA; MacLennan AH; Maki P; Palacios S; Shah D; Villaseca P; Warren M
    Climacteric; 2011 Oct; 14(5):515-28. PubMed ID: 21848495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Severity of menopausal symptoms and use of both conventional and complementary/alternative therapies.
    Keenan NL; Mark S; Fugh-Berman A; Browne D; Kaczmarczyk J; Hunter C
    Menopause; 2003; 10(6):507-15. PubMed ID: 14627858
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of vasomotor symptoms in the menopausal transition and postmenopausally: psychiatric comorbidity.
    Alexander JL; Burger H; Dennerstein L; Woods NF; Davis SR; Kotz K; Van Winkle J; Richardson G; Ratka A; Kessel B
    Expert Rev Neurother; 2007 Nov; 7(11 Suppl):S115-37. PubMed ID: 18039061
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Undertreatment of menopausal symptoms and novel options for comprehensive management.
    Lewis V
    Curr Med Res Opin; 2009 Nov; 25(11):2689-98. PubMed ID: 19775194
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MF-101, an estrogen receptor beta agonist for the treatment of vasomotor symptoms in peri- and postmenopausal women.
    Stovall DW; Pinkerton JV
    Curr Opin Investig Drugs; 2009 Apr; 10(4):365-71. PubMed ID: 19337958
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Physiologic aspects of natural and surgical menopause.
    Bachmann G
    J Reprod Med; 2001 Mar; 46(3 Suppl):307-15. PubMed ID: 11310451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An overview of menopause associated vasomotor symptoms and options available in its management.
    Okeke TC; Ezenyeaku CC; Ikeako LC; Agu PU
    Niger J Med; 2013; 22(1):7-14. PubMed ID: 23441513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vasomotor menopausal symptoms and risk of coronary heart disease: a life course perspective.
    Hardy R
    Menopause; 2011 Feb; 18(2):127-8. PubMed ID: 21135711
    [No Abstract]   [Full Text] [Related]  

  • 13. Vaginal, endometrial, and reproductive hormone findings: randomized, placebo-controlled trial of black cohosh, multibotanical herbs, and dietary soy for vasomotor symptoms: the Herbal Alternatives for Menopause (HALT) Study.
    Reed SD; Newton KM; LaCroix AZ; Grothaus LC; Grieco VS; Ehrlich K
    Menopause; 2008; 15(1):51-8. PubMed ID: 18257142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of menopausal vasomotor symptoms.
    Obstet Gynecol; 2005 May; 105(5 Pt 1):1137-9. PubMed ID: 15863558
    [No Abstract]   [Full Text] [Related]  

  • 15. Diagnosis and management of mood disorders during the menopausal transition.
    Cohen LS; Soares CN; Joffe H
    Am J Med; 2005 Dec; 118 Suppl 12B():93-7. PubMed ID: 16414333
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effectiveness of sublingual and topical compounded bioidentical hormone replacement therapy in postmenopausal women: an observational cohort study.
    Ruiz AD; Daniels KR
    Int J Pharm Compd; 2014; 18(1):70-7. PubMed ID: 24881343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of menopausal symptoms post-Women's Health Initiative: refinement of existing treatments and development of new therapies.
    Honebrink A
    Expert Opin Emerg Drugs; 2005 Aug; 10(3):619-41. PubMed ID: 16083332
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hormone replacement therapy and beyond. The clinical challenge of menopausal symptoms in breast cancer survivors.
    Mortimer JE
    Geriatrics; 2002 Sep; 57(9):25-31. PubMed ID: 12271826
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adiposity and reporting of vasomotor symptoms among midlife women: the study of women's health across the nation.
    Thurston RC; Sowers MR; Chang Y; Sternfeld B; Gold EB; Johnston JM; Matthews KA
    Am J Epidemiol; 2008 Jan; 167(1):78-85. PubMed ID: 17881385
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Controversies surrounding on hormone replacement therapy during menopause].
    Cravioto MC
    Gac Med Mex; 2006; 142 Suppl 2():33-42. PubMed ID: 19031677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.